NEOG Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q3

FY2026Q4

208.50M

-9.84%

0.057

-48.48%

200.80M

-9.13%

0.077

-23.33%

206.88M

-8.24%

0.090

+80%

Estimates Revision

The market is revising Upward the revenue expectations for Neogen Corporation (NEOG) for FY2026, with the revenue forecasts being adjusted by 0.32% over the past three months. During the same period, the stock price has changed by 59.27%.

Revenue Estimates for FY2026

Revise Upward

+0.32%

In Past 3 Month

EPS Estimates for FY2026

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+59.27%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast NEOG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEOG is 8.17 USD with a low forecast of 6.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

3 Hold

0 Sell

Hold

Current: 0.000

Low

6.50

Averages

8.17

High

10.00

Current: 0.000

Low

6.50

Averages

8.17

High

10.00

Guggenheim

Buy

maintain

$8 -> $12

2026-01-09

New

Reason

Guggenheim

Price Target

$8 -> $12

2026-01-09

New

maintain

Buy

Reason

Guggenheim raised the firm's price target on Neogen to $12 from $8 and keeps a Buy rating on the shares after the company beat revenue and EBITDA expectations and raised guidance. While stating that one quarter "does not make a trend," the firm adds that the portfolio performed well and cost actions "clearly are starting to take hold."

CJS Securities

Robert Labick

Market Perform -> Outperform

upgrade

$10

2025-12-10

Reason

CJS Securities

Robert Labick

Price Target

$10

2025-12-10

upgrade

Market Perform -> Outperform

Reason

CJS Securities analyst Robert Labick upgraded Neogen to Outperform from Market Perform with a $10 price target.

Piper Sandler

David Westenberg

Neutral

maintain

2025-10-16

Reason

Piper Sandler

David Westenberg

Price Target

2025-10-16

maintain

Neutral

Reason

Piper Sandler analyst David Westenberg raised the firm's price target on Neogen to $6.50 from $5 following quarterly results. The firm keeps a Neutral rating on the shares.

CJS Securities

initiated

$10

2025-09-29

Reason

CJS Securities

Price Target

$10

2025-09-29

initiated

Reason

CJS Securities initiated coverage of Neogen with a Market Perform rating and $10 price target.

William Blair

Outperform -> Market Perform

downgrade

2025-07-29

Reason

William Blair

Price Target

2025-07-29

downgrade

Outperform -> Market Perform

Reason

William Blair downgraded Neogen to Market Perform from Outperform. The firm had remained bullish because of what it had seen as sales and profitability growth potential, but management pointed to a worsening macro environment that resulted in fiscal 2026 revenue guidance that implies flat to declining revenues. In this context, the firm does not see \"a pathway to improving markets, leaving us with tepid fiscal 2026 guidance,\" the analyst tells investors.

Guggenheim

Buy

downgrade

$13 -> $10

2025-06-30

Reason

Guggenheim

Price Target

$13 -> $10

2025-06-30

downgrade

Buy

Reason

Guggenheim lowered the firm's price target on Neogen to $10 from $13 and keeps a Buy rating on the shares. The firm's updated model includes a pro forma outlook of Neogen assuming current divestiture plans are finalized, as well as management's recent commentary on higher-than-anticipated inventory write-offs, which extends through 2026, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Neogen Corp (NEOG.O) is 21.65, compared to its 5-year average forward P/E of 40.26. For a more detailed relative valuation and DCF analysis to assess Neogen Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

40.26

Current PE

21.65

Overvalued PE

60.30

Undervalued PE

20.23

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

21.09

Current EV/EBITDA

12.71

Overvalued EV/EBITDA

31.92

Undervalued EV/EBITDA

10.26

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

4.65

Current PS

1.84

Overvalued PS

7.23

Undervalued PS

2.07

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 999.08% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NEOG News & Events

Events Timeline

No data

News

9.5

01-08Barron's

PinnedNeogen Shares Soar Following Strong Earnings Report and Increased 2026 Forecast

9.5

01-09Benzinga

WD-40 Co Reports Q1 Earnings Miss, Shares Drop 9.1%

6.0

01-09NASDAQ.COM

Neogen Corp (NEOG) Stock Surpasses Analyst Target Price at $9.70

People Also Watch

Frequently Asked Questions

What is Neogen Corp (NEOG) stock price today?

The current price of NEOG is 9.62 USD — it has decreased -0.93 % in the last trading day.

What is Neogen Corp (NEOG)'s business?

Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

What is the price predicton of NEOG Stock?

What is Neogen Corp (NEOG)'s revenue for the last quarter?

Neogen Corp revenue for the last quarter amounts to 224.69M USD, decreased -2.84 % YoY.

What is Neogen Corp (NEOG)'s earnings per share (EPS) for the last quarter?

Neogen Corp. EPS for the last quarter amounts to -0.07 USD, decreased -96.67 % YoY.

What changes have occurred in the market's expectations for Neogen Corp (NEOG)'s fundamentals?

How many employees does Neogen Corp (NEOG). have?

Neogen Corp (NEOG) has 2974 emplpoyees as of January 10 2026.

What is Neogen Corp (NEOG) market cap?

Today NEOG has the market capitalization of 2.09B USD.